ArticleBMC musculoskeletal disorders2025
Impact of sarcopenia on the clinical efficacy of delta large-channel endoscopic treatment of lumbar spinal stenosis in older adults: a retrospective cohort study.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundExploring the effect of sarcopenia on the clinical outcome of delta large-channel endoscopic treatment of elderly patients with lumbar spinal stenosis.
methodsData were collected from 87 patients who underwent delta large-channel endoscopy between January 2022 and June 2023 at the First Affiliated Hospital of Ningbo University. Skeletal muscle index at the L3 level SMI < 36 cm
resultsThere were no significant differences in gender, age, BMI, intraoperative bleeding, operative time, hospitalization time, and complication occurrence between the two groups (P > 0.05). Surgery was successfully completed in both groups. Clinical outcomes, such as lumbar VAS scores was not significant different between the two groups (P > 0.05). While comparing the lumbar VAS scores between the two groups at 6 months and 12 months postoperatively, the scores of the non- sarcopenia group were lower than those of the sarcopenia group, and the difference was statistically significant (P < 0.05). In addition, in the postoperative follow-up at 3 months, 6 months and 12 months, the comparison of ODI scores and JOA scores between the sarcopenia group and the non-sarcopenia group was statistically significant (P < 0.05), in which the ODI scores of the non-sarcopenia group were significantly lower than those of the sarcopenia group, and the JOA scores of the non-sarcopenia group were significantly higher than those of the sarcopenia group.
conclusionFunctional recovery after delta large-channel endoscopic decompression was better in non-sarcopenia patients than in the sarcopenia group, and sarcopenia had a greater impact on long-term postoperative outcomes in older patients. We need to emphasize the diagnosis and intervention of sarcopenia in patients to reduce the impact of sarcopenia on postoperative clinical outcomes. Whether sarcopenia affects the stability of lumbar spine in endoscopic patients requires a longer follow-up period and later studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.